CONMED Corp

CNMD

Explore Our Financial Data > Companies > CONMED Corp

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	CNMD
CIK	0000816956
SIC	3845
Sector	Manufacturing
Industry Category	Medical Equipment
Industry Group	Surgical, Medical, And Dental Instruments And Supplies

Contact

Address	11311 CONCEPT BOULEVARD, LARGO, FL, 33773
Website	conmed.com
Phone	727-214-2974
CEO	Curt R. Hartman
Employees	4,100

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$1.33 billion
Pre-Tax Income	$137.69 million
Net Income	$110.20 million
Net Income to Common	$110.20 million
EPS	$3.54

View All

Balance Sheet

Cash	$33.94 million
Assets	$2.33 billion
Liabilities	$1.33 billion
Common Equity	$1.00 billion
Liabilities & Equity	$2.33 billion

View All

Cash Flow Statement

Net Income	$110.20 million
Cash From Operating Activities	$165.21 million
Cash From Investing Activities	$-16.12 million
Cash From Financing Activities	$-144.83 million
Change in Cash	$5.07 million

View All

Calculations

NOPAT	$137.92 million
EBITDA	$250.85 million
Price to Earnings	$15.31
Price to Book	$1.68
ROE	11.69%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

5 Must-Read Analyst Questions From CONMED’s Q2 Earnings Call

CONMED’s second quarter saw a positive market response, as the company’s revenue and non-GAAP profit exceeded Wall Street’s expectations. Management highlighted worldwide general surgery growth, led by its AirSeal and Buffalo Filter platforms, as the main drivers of performance. CEO Patrick Beyer underscored the impact of supply chain improvements and strong demand for new products like BioBrace in orthopedics. Despite ongoing cost pressures, the company’s operational enhancements and product mo

Article Link

CNMD Q2 Deep Dive: Product Growth and Supply Chain Progress Offset Margin Pressure

Medical tech company CONMED (NYSE:CNMD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.1% year on year to $342.3 million. The company expects the full year’s revenue to be around $1.37 billion, close to analysts’ estimates. Its non-GAAP profit of $1.15 per share was 2.4% above analysts’ consensus estimates.

Article Link

Why Conmed (CNMD) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Article Link

CONMED's (NYSE:CNMD) Dividend Will Be $0.20

CONMED Corporation ( NYSE:CNMD ) will pay a dividend of $0.20 on the 3rd of October. This means the dividend yield will...

Article Link

Additional Considerations Required While Assessing CONMED's (NYSE:CNMD) Strong Earnings

CONMED Corporation's ( NYSE:CNMD ) stock was strong after they recently reported robust earnings. We did some analysis...

Article Link